Intended for healthcare professionals

  1. Education
  2. Personalized evidence...
  3. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
Clinical Review State of the Art Review

Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4245 (Published 10 December 2018) Cite this as: BMJ 2018;363:k4245

Data supplement

  • Web Extra

    • Data Supplement - Appendix 1: Supplemental table 1 describing primary methodological papers related to predictive heterogeneity of treatment effect

Related articles

See more

Cited by...

  • Individual Differences in the Effects of Neighborhood Socioeconomic Deprivation on Economic Decision Making and Psychotic Risk in Children
  • Time to treatment with bridging intravenous alteplase before endovascular treatment:subanalysis of the randomized controlled SWIFT-DIRECT trial
  • Heterogeneity of treatment effects by risk in pulmonary arterial hypertension
  • Heterogeneous treatment effects of intensive glycemic control on kidney microvascular outcomes in ACCORD
  • Time to treatment with bridging intravenous alteplase before endovascular treatment:subanalysis of the randomized controlled SWIFT-DIRECT trial
  • Calcium supplementation to prevent pre-eclampsia: protocol for an individual participant data meta-analysis, network meta-analysis and health economic evaluation
  • Heterogeneity in the Effects of Neighborhood Deprivation on Economic Decision Making and Mental Health in Children
  • Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors
  • Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
  • Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
  • Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: An application for type 2 diabetes precision medicine
  • Prediction model study focusing on eHealth in the management of urinary incontinence: the Personalised Advantage Index as a decision-making aid
  • Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical data
  • The automation of doctors and machines: A classification for AI in medicine (ADAM framework)
  • Identifying adults with acute rhinosinusitis in primary care that benefit most from antibiotics: protocol of an individual patient data meta-analysis using multivariable risk prediction modelling
  • Tocilizumab in COVID-19 - A Bayesian reanalysis of RECOVERY
  • An Electronic Health Record Compatible Model to Predict Personalized Treatment Effects from the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real World Data
  • Predictive approaches to heterogeneous treatment effects: a systematic review
  • Strategies to reduce antibiotic use in women with uncomplicated urinary tract infection in primary care: protocol of a systematic review and meta-analysis including individual patient data
  • Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment
  • Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial
  • Graphing and reporting heterogeneous treatment effects through reference classes
Back to top